SB431542

SB431542 suppresses TGF-β-induced proliferation of human osteosarcoma cells. SB431542 treatment of glioma cultures inhibited proliferation, TGF-β-mediated morphologic changes, and cellular motility. Small molecule inhibitors of TGF-β receptors may offer a novel therapy for malignant gliomas by reducing cell proliferation, angiogenesis, and motility.

Read more
€0.00 (tax incl.)
Reference:
SM33-200
Product Details
SM33-200

Data sheet

Size
200 mg
URL - Product
http://cellgs.e2ecdn.co.uk/Downloads/SM33_datasheet.pdf

Menu

Settings